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Erythema nodosum (EN) is the most frequent clinicopathologic variant of panniculitis with painful red or violaceous nodules on
the anterior surfaces of the legs. The condition is a cutaneous reaction that might be associated with a wide variety of disorders or
might be caused by medications that produce painful nodules on the shins, and less commonly on the thighs and forearms. In this
paper, we describe, for the ﬁrst time in the world, erythema nodosum as the simultaneous presenting complaint of monozygotic
twinsistersafterstreptococcalpharyngitis.Thispapermightsupporttheeﬀectofheredityintheoccurrenceoferythemanodosum.
1.Introduction
Erythema nodosum (EN) is clinically presented as an
acute, ill-deﬁned, nonulcerative, erythematous. and painful
eruption, which is usually conﬁned to the extensor aspects
of lower extremities. Females comprise the majority of the
patients. Erythema nodosum is probably the most common
type of panniculitis and a delayed hypersensitivity reaction
to a variety of antigens. The condition might be associated
with a wide variety of etiologic factors, such as medications,
infections, systemic inﬂammatory diseases, malignancies,
sarcoidosis, rheumatologic disorders, inﬂammatory bowel
diseases, pregnancy, and so on [1]. In 60% of EN cases, no
cause is found [2].
Typically, EN is manifested by the sudden onset of
symmetrical, tender, erythematous, warm nodules, and
raised plaques, usually located on the shins, ankles, and
knees and the lesions are often distributed bilaterally
[2]. Diagnosis is usually based on a compatible clinical
presentation. In patients with atypical features, deep skin
biopsy is necessary for conﬁrmation. The typical pathologic
presentation is septal panniculitis, with inﬁltration of
neutrophils, lymphocytes, and even multinucleated giant
cells in the periseptal areas of fat lobules. Vascular deposition
of immunoglobulin complexes and complement has been
hypothesized as the etiologic factors involved in septal
panniculitis, but evidence of this pathophysiological process
remains elusive [1] .T r e a t m e n to fE Ns h o u l db ed i r e c t e dt o
the underlying associated condition if identiﬁed. In most
patients, EN is a self-limited disease and usually nodules of
EN regress spontaneously within a few weeks, requiring only
symptomatic relief using nonsteroidal anti-inﬂammatory
drugs, potassium iodide, cool wet compresses, elevation, and
bed rest. Systemic corticosteroids are rarely indicated in EN,
and an underlying infection should be ruled out before they
are administered [1–3].
2.CaseReport
In this case report, for the ﬁrst time in the world, we
describe erythema nodosum as the simultaneous presenting
complaint of monozygotic twin sisters after streptococcal
pharyngitis (Figure 1(a)).
It should be noted that both patients provided their
informed consent.
2.1. Case One. A married 22-year-old lady presented with a
chief complaint of tenderness, heat, and pain in the anterior2 Case Reports in Medicine
(a)
(b) (c)
Figure 1: Skin lesions: case 1 on the right side and case 2 on the left side.
parts of both legs of one-week duration; no pitting edema
was present. The signs had gradually developed on the lower
one-third of the right leg in an area 3–5cm in diameter and
on the left leg in an area 4-5cm in diameter. In the physical
examination, the patient was ill without fever and erythema,
and nodular lesions were seen (Figure 1(b)).
2.2. Case Two. A married 22-year-old lady presented with
a chief complaint of pain and tenderness on the anterior
part of her right leg, which gradually increased in intensity;
the same problems appeared on the left leg, too. Physical
examination revealed 0.5 × 0.5cm nodules with 3–50cm
erythematous margins. She was ill but afebrile (Figure 1(c)).
Both the patients reported sore throat, fever, chills,
and general symptoms of a cold two weeks previously and
reported taking oral contraceptives. Physical examination
did not yield any abnormal ﬁndings. After 8 weeks, the
conditions completely resolved. During the sickness period
the patients received a single dose of penicillin 1200000 U
intramuscularly and nonsteroidal anti-inﬂammatory drugs.
After 8 weeks the conditions completely resolved.
3.LaboratoryFindings
Table 1 presents the laboratory data of the two cases.
4. Discussion
The eruptive phase of erythema nodosum starts with
ﬂulike symptoms of fever and generalized aches and pains.
Arthralgia might occur and appear before or during the
eruptive phase. Most lesions in infection-induced erythema
nodosum ameliorate within 7 weeks, but active disease may
last up to 18 weeks. In contrast, 30% of idiopathic erythema
nodosum cases may last more than 6 months. Febrile illness
with dermatologic ﬁndings includes abrupt onset of illness
with initial fever, followed by a painful rash within 1-2 days
[4]. When erythema nodosum is diagnosed, it is important
to ﬁnd out the underlying conditions. These include a
detailed history, including drug and past medical history, a
careful physical examination, laboratory investigation, and a
chest X-ray.
EN is classiﬁed as idiopathic or secondary to other
diseases [5]. Some causes of erythema nodosum and its
diﬀerential diagnosis are listed in Table 1. There are various
etiologic factors for erythema nodosum based on the disease
pattern of the region. Table 2 presents some retrospective
studies that show this variation based on geographical
diﬀerences [3, 6–9].
The relationship between a previous episode of upper
respiratory tract infection by group A beta-hemolytic strep-
tococci and erythema nodosum is fully known, particularly
in children and young adults. Usually, the cutaneous lesions
appear 2-3 weeks after throat infection, and they are
associated with an increase in antistreptolysin O (ASO) titer.
An intradermal positive test to streptococcal antigens is
often found in patients with erythema nodosum secondary
to streptococcal infections, although when the cutaneous
nodules develop, the cultures of ordinary throat swabs
usually do not detect microorganisms [1, 10].Case Reports in Medicine 3
Table 1: Laboratory data of the two cases.
Tests Case one Case two Normal value
Throat culture Strep B hemolytic group A Strep B hemolytic group A Negative
Cold agglutination Negative Negative lower than 1:32
White blood cell 10100 7400 4.3–10.8 × 103/mm3
Neutrophil 72% 70% 45–74%
Red blood cell 3.58 4.22 3.5–5 × 106/mcL
Hemoglobin 9.6 11.4 12.1–15.3g/dL
Platelets 315000 334000 150–450 × 103/mcL
Erythrocyte sedimentation rate 75 39 30mm/hr
C-reactive protein 2+ 1+ no CRP detectable
ASO 400 200 less than 160 Todd units per milliliter
PPD Negative Negative Negative
Chest X-ray Normal Normal Normal
Table 2: Retrospective studies that show variation according to geographical diﬀerences.
Author Year Number of cases Country Idiopathic Infection
Carlos et al. [6] 2000 106 patients (82 females) Spain 35% 34%
Psychos et al.[3] 2000 110 females Greece 35% 17.3%
Tay [7] 2000 75 patients (65 females) Singapore 60% 29%
Puavilai et al. [8] 1995 100 patients (88 females) Thailand 72% 18%
Drugs are frequently implicated as the cause of erythema
nodosum. Sulfonamides, bromides, and oral contraceptives
have long been established as the most common medications
contributing to EN. In those patients who develop erythema
nodosumwhenanantibioticistakenforaninfectiousdisease
it is diﬃcult to determine whether the cutaneous reaction is
due to the antibiotic or due to the infectious agent [1, 11].
In publications and data bases, there is no report
about simultaneous occurrence of erythema nodosum in
monozygotic twins or in a family. Almost none of the
studies reveal anything about genetics and heredity in the
etiology of EN. Labunski et al. reported that patients with
erythema nodosum associated with sarcoidosis produce an
uncommon tumor necrosis factor (TNF-II). These patients
show a nucleotide exchange, (G-A) at position 308 in the
human TNF gene promoter, whereas patients with erythema
nodosum without underlying sarcoidosis display a similar
allele frequency compared with controls [12]. These results
support the notion that erythema nodosum, in association
with sarcoidosis, might be pathogenetically linked to altered
TNF-α production due to a genetic promoter polymorphism
[1, 3, 5]. In contrast, other authors have found that
the proinﬂammatory cytokine pattern exhibits increased
interleukin-6 serum concentrations both in infectious and
noninfectious disease-related erythema nodosum, whereas a
minor involvement of TNF is found in these patients [1, 11].
Our paper might help researchers elucidate the patho-
genesis of EN. In addition, this paper might have diagnostic
value in identifying patients with speciﬁc conditions associ-
ated with EN.
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